Published March 31, 2021 | Version V1.2
Dataset Open

Expert elicitation data on future perspectives regarding whole genome sequencing in clinical oncology

  • 1. Technical Medical Centre, University of Twente, Enschede, the Netherlands
  • 2. Maastricht University Medical Center, Maastricht, The Netherlands; Maastricht University, Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands
  • 3. Technical Medical Centre, University of Twente, Enschede, the Netherlands; University of Melbourne, University of Melbourne Centre for Cancer Research, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia
  • 4. Technical Medical Centre, University of Twente, Enschede, the Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, the Netherlands
  • 5. Technical Medical Centre, University of Twente, Enschede, the Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, the Netherlands; Rijnstate General Hospital, Arnhem, the Netherlands

Description

This dataset contains data on:

(1) barriers and facilitators that were prioritized from most to least important by international experts in a pilot survey,

(2) expert elicitations on likelihoods of future scenarios regarding the implementation of whole genome sequencing within the field of clinical oncology.

Notes

The "Technology Assessment of Next Generation Sequencing in Personalized Oncology" (TANGO) project is funded by the ZonMw Personalised Medicine Programme under Dossier number: 846001002 in collaboration with KWF and Zilveren Kruis. The project period is 31 December 2016 – 31 May 2021.

Files

readme_output v1.2.txt

Files (50.0 kB)

Name Size Download all
md5:2b860f370ef95363a79c0c529e5bf9c9
11.8 kB Download
md5:23a2e596ec3f8febd679f30e032c90d1
34.7 kB Download
md5:6629c69d0322a9da62f60659ca9214f1
3.5 kB Preview Download

Additional details

Related works

Is supplement to
Journal article: 10.1186/s12885-021-08214-8 (DOI)